Advertisement

Topics

Korlyns Pharmaceuticals International UK Company Profile

18:12 EST 18th December 2018 | BioPortfolio

The company started from a humble beginning as CIJEY NIG. LTD IN 1984. Then it operated as a general trading Company in the importation of general goods, and cosmetics from China and the U.K. Cijey were also agents to several local manufacturing Industries.In 1996 Cijey diversified into the Pharmaceutical Industry, initially as distributors to several local manufacturing outfits, Pharmaceutical importers and Pharmaceutical Multinational Corporations. This was taken a step further with the importation of Pharmaceutical products from the United Kingdom. With the increased sales and the uniqueness of the Pharmaceutical market, it was decided to separate the pharmaceutical business of Cijey, and Korlyns Pharmaceuticals was created in January 2000, and was fully incorporated as a Limited Liability company in February 2002.

Location

404 Katherine Road
London
London
E7 8NP
United Kingdom

Contact

Phone: 44- 020 8472 0461
Fax: 44- 020 8471 3335
Email: enquiries@korlynspharm.com


News Articles [754 Associated News Articles listed on BioPortfolio]

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

December 11 – 12, 2018 Workshops, December 10, 2018 The Revere Hotel 200 Stuart St., Boston, MA SVP R&D leading workshop on Financial Planning and Commercial DevelopmentSVP R&D to pre...

Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Valeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance ReportSummaryValeant Pharmaceuticals International, Inc. Strategy, SWOT and Corporate Finance Report, is a source of ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX

NEW YORK, June 19, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Valeant Pharmaceuticals International, Inc. ("Valeant" or the "Company") (NYSE: VRX). Such i...

Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals Announces Scientific Innovation Award Received at International Cannabis Research Society Conference

SAN DIEGO, CA / ACCESSWIRE / August 21, 2018 / Emerald Health Pharmaceuticals Inc. (EHP), a company developing medicines based on cannabinoid science, today announced that Carmen Navarrete, Ph.D., ...

Valeant Pharmaceuticals International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Valeant Pharmaceuticals International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Valeant Pharmaceuticals International, Inc. Mergers Acquisition...

Novartis International AG: Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals

Novartis International AG / Novartis licenses three novel anti-infective programs to Boston Pharmaceuticals . Processed and transmitted by West Corporation. The issuer is solely responsible for the...

Valeant Pharmaceuticals International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 26062018] Prices from USD $350

Valeant Pharmaceuticals International, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Valeant Pharmaceuticals International, Inc. Mergers Acquisition...

Valeant Pharmaceuticals agrees to divest $2.1bn in assets

Valeant Pharmaceuticals International has agreed to sell about $2.1bn in assets as it seeks to reduce over $30bn in debt.

PubMed Articles [645 Associated PubMed Articles listed on BioPortfolio]

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates.

Pharmaceuticals and personal care products are an integral part of societal health yet their presence in various environmental compartments, including treated wastewaters, has sparked concerns towards...

Sensitivity of physiological and biochemical endpoints in early ontogenetic stages of crops under diclofenac and paracetamol treatments.

Early stages of ontogenesis determining subsequent growth, development, and productivity of crops can be affected by wastewater and sludge contaminated with pharmaceuticals. Diclofenac (DCF) and parac...

Clinical Trials [1288 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good Clinical Pr...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Companies [2655 Associated Companies listed on BioPortfolio]

Korlyns Pharmaceuticals International UK

The company started from a humble beginning as CIJEY NIG. LTD IN 1984. Then it operated as a general trading Company in the importation of general goods, and cosmetics from China and the U.K. Cijey we...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Alantos Pharmaceuticals Holding, Inc.

Alantos Pharmaceuticals is a dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals for Arthritic and Metabolic diseases. Headquartered in Cambridge, MA, ...

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prost...

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The...

More Information about "Korlyns Pharmaceuticals International UK" on BioPortfolio

We have published hundreds of Korlyns Pharmaceuticals International UK news stories on BioPortfolio along with dozens of Korlyns Pharmaceuticals International UK Clinical Trials and PubMed Articles about Korlyns Pharmaceuticals International UK for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Korlyns Pharmaceuticals International UK Companies in our database. You can also find out about relevant Korlyns Pharmaceuticals International UK Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record